77
Views
0
CrossRef citations to date
0
Altmetric
CORRIGENDUM

Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice [Corrigendum]

Pages 2833-2834 | Received 12 Sep 2023, Accepted 12 Sep 2023, Published online: 16 Sep 2023
This article refers to:
Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice

Niu S, Ren Q, Chen S, et al. Diabetes Metab Syndr Obes. 2023;16:2549–2560.

The authors have advised the correspondence section on page 2549 is incorrect. The correct correspondence details are as follows.

Correspondence: Shuchun Chen, Department of Endocrinology, Hebei General Hospital, Shijiazhuang, Hebei, People’s Republic of China, Email [email protected]

The authors apologize for this error.